FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Momenta Begins Phase 2/3 Nipocalimab Study

FDA allows Momenta Pharmaceuticals to begin an adaptive Phase 2/3 clinical study for its FcRn inhibitor nipocalimab in warm autoimmune hemolytic anemi...

Human Drugs

Turalio Approved for Tenosynovial Giant Cell Tumor

FDA approves a Daiichi Sankyo NDA for Turalio (pexidartinib) capsules for treating adult patients with symptomatic tenosynovial giant cell tumor.

Medical Devices

Qiagen Recalls QIAsymphony Filter Tips

Qiagen recalls filter tips for use with the QIAsymphony SP/AS instruments due to their potential to leak and affect test results.

Medical Devices

Teleflex Recalls Sheridan Endotracheal Tubes/Connectors

Teleflex recalls certain Sheridan endotracheal tubes and connectors, which are also used in Centurions convenience kits.

Human Drugs

Pathology Peer Review Q&A Guidance

FDA issues a draft guidance with information for sponsors and nonclinical laboratory staff about the management and conduct of pathology peer review p...

Medical Devices

MR Testing, Labeling Guidance

FDA issues a draft guidance on testing and labeling medical devices for safety in the magnetic resonance environment.

Human Drugs

Bacterial Vaginosis Drug Development Guidance

FDA issues a final guidance on developing drugs to treat bacterial vaginosis.

Federal Register

Draft Guide on Drug Study General Considerations

Federal Register notice: FDA makes available a draft guidance entitled E8(R1) General Considerations for Clinical Studies.

Medical Devices

FDA, Dassault Systmes Extend Collaboration

FDA extends for five years its medical device innovation collaboration with Frances Dassault Systmes.

Human Drugs

FDA Expanded OK for Leo Pharmas Psoriasis Therapies

FDA expands the approval for Leo Pharmas Enstilar and Taclonex to treat plaque psoriasis in patients 12 years and older.